New Zealand's cardiovascular advisory committee rated it a high priority. Wegovy is used there now but patients pay the full cost themselves.
Recap by typeshit. Full story at RNZ.
A rule in Ohio's administrative code blocks Medicaid from covering the drugs for obesity in adults, though teens under 18 are covered under federal law.
Health minister Dzulkefly says the government did not set aside dedicated 2026 budget funds for the two GLP-1 treatments.
Sales missed forecasts by about $33 million, but Lilly says demand more than tripled. Novo's Wegovy pill still holds roughly 75% of oral GLP-1 scripts.
Employers pick their own contribution toward semaglutide shots or pills. AJMC notes WTW found GLP-1 weight loss coverage fell to 53% of employers, the first drop in three years.
Ennis says no one asked about her surgical history or anemia before she began, and she later needed a transfusion. She lists questions clinicians should ask.
19:37
Dermatologist Dr Dray looks at the safety of popular injectable peptides like BPC-157 and TB-500 that are marketed for anti-aging.
Loading…